CUV 0.64% $13.87 clinuvel pharmaceuticals limited

who 's the winner?, page-2

  1. 131 Posts.
    Based on the news released around the time of the jump, it doesn't look as if it had anything to do with their Melanotan II derivative, PT-141 (bremelanotide). So not much to see here, except that it'd be nice if Clinuvel did the same sooner or later.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.